March 3, 2021
Preventing a serious cardiac event is a top priority for my patients, but the Institute for Clinical and Economic Review is about to make prevention a whole lot harder.
January 7, 2021
When it comes to incorporating patients into decisions about medication and value, the United States just isn’t making the grade.
December 15, 2020
When you or someone you love has a cardiovascular event, life gets real – fast.
December 10, 2020
Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community. Read the Letter
November 2, 2020
Open enrollment comes at a busy time of year, so it can be tempting to rush through the process.
October 9, 2019
The controversial Institute for Clinical and Economic Review has done something unprecedented: admitted it’s wrong.
August 20, 2019
Medicare beneficiaries nationwide will soon have coverage for cutting-edge CAR-T cancer therapy, the Centers for Medicare and Medicaid Services announced this month.
April 9, 2019
Policymakers, providers and patients all feel the impact of The Institute for Clinical and Economic Review, whose ubiquitous cost-effectiveness reports can determine patients’ access to medicine.
February 1, 2019
Monthly subscription for streaming music? Sure. Unlimited gym access? Of course. Favorite Netflix shows? Yep. But hepatitis C treatment by subscription?
January 25, 2019
“Important Prescription Plan Change,” the letter announced. “We’re writing to inform you of an important upcoming change to your specialty prescription benefits.”